NNM Securities

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark

BSE1071.65-8.4 (-0.78 %)

PREV CLOSE ( ) 1080.05

OPEN PRICE ( ) 1092.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 19082

TODAY'S LOW / HIGH ( )1063.65 1098.00

52 WK LOW / HIGH ( )520.1 1095.95

NSE1071.10-8.25 (-0.76 %)

PREV CLOSE( ) 1079.35

OPEN PRICE ( ) 1090.00

BID PRICE (QTY) 1071.10 (494)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 442802

TODAY'S LOW / HIGH( ) 1063.05 1098.00

52 WK LOW / HIGH ( )520.1 1096

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-11 1977

Management Info

Glenn Saldanha - Chairman Glenn Saldanha - Managing Director

Registered Office

Address B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,
Mumbai,
Maharashtra-400026

Phone

Email complianceofficer@glenmarkpharma.com

Website www.glenmarkpharma.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

29Apr Glenmark Pharmaceuticals gets USFDA’s
Glenmark Pharmaceuticals (Glenmark) has received final approval by the U..

29Apr Glenmark Pharmaceuticals moves up on g
Glenmark Pharmaceuticals is currently trading at Rs. 1088.25, up by 8.20..

29Apr Glenmark Pharmaceuticals informs about
Glenmark Pharmaceuticals has informed that it attached media release tit..

10Apr Glenmark Pharmaceuticals recalls 6,528
Glenmark Pharmaceuticals is recalling 6,528 bottles of Diltiazem Hydroch..

01Apr Glenmark Pharmaceuticals informs about
Pursuant to Regulation 30 of the Securities and Exchange Board of India..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	-204.089999999999	12087.69
Gross Profit	-755.019999999999	15718.74
Operating Profit	745.470000000001	24587.06
Net Sales	13650.96	82206.62

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 26277.60 (1.60%)	M.Cap (Rs. in Cr)55810.97
Neuland Laboratories (BSE) 7203.10 (3.14%)	M.Cap (Rs. in Cr)9220.65
Astrazeneca Pharma I (BSE) 5556.10 (2.60%)	M.Cap (Rs. in Cr)13875.00
Medicamen Biotech (BSE) 589.55 (20.00%)	M.Cap (Rs. in Cr)749.59
Fredun Pharma (BSE) 934.45 (10.49%)	M.Cap (Rs. in Cr)441.22

Shareholding Pattern

	PROMOTERS	46.64%
	NON-INSTITUTION	18.58%
	MUTUAL FUNDS/UTI	10.55%
	FI/BANKS/INSURANCE	2.39%
	GOVERNMENT	0.04%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Baroda BNP Paribas ...	3.56
Bank of India Arbit...	2.99
Axis Nifty Smallcap...	2.77
Aditya Birla SL Nif...	2.74
Kotak Nifty Smallca...	2.72
Aditya Birla SL Mid...	2.36
Aditya Birla SL Mfg...	2.20

ATTENTION INVESTORSKYCIPO

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :

Assamese	Bengali	Gujrati	Hindi	Kanada
Kashmiri	Konkani	Malyalam	Marathi	Oriya
Punjabi	Sindhi	Tamil	Telegu	Urdu

REGISTRATION NOS.

Filing compliant on SCORES – Easy & quick

Register on SCORES portal
Mandatory details for filing complaints on SCORES:
- Name
- PAN
- Address
- Mobile Number
- E-mail ID
Benefits:
- i.) Effective communication
- ii.) Speedy redressal of the grievances

SMART ODR Portal

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

NNM Securities

Smart Quotes

GLENMARK PHARMACEUTICALS LTD.

Filing compliant on SCORES – Easy & quick